HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shao-Hui Cai Selected Research

Neoplasms (Cancer)

3/2018AP-1 confers resistance to anti-cancer therapy by activating XIAP.
3/2017Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro.
10/2016Nodal signaling modulates the expression of Oct-4 via nuclear translocation of β-catenin in lung and prostate cancer cells.
5/2016Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression.
6/2014Identification of potential pathways involved in the induction of cell cycle arrest and apoptosis by a new 4-arylidene curcumin analogue T63 in lung cancer cells: a comparative proteomic analysis.
8/2013Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
3/2013Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression.
1/2013Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.
5/2011A new tumor vaccine: FAPτ-MT elicits effective antitumor response by targeting indolamine2,3-dioxygenase in antigen presenting cells.
11/2010Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shao-Hui Cai Research Topics

Disease

15Neoplasms (Cancer)
03/2018 - 05/2003
4Lung Neoplasms (Lung Cancer)
01/2016 - 12/2012
3Prostatic Neoplasms (Prostate Cancer)
10/2016 - 10/2014
3Neoplasm Metastasis (Metastasis)
08/2013 - 10/2009
3Hepatocellular Carcinoma (Hepatoma)
11/2003 - 05/2003
2Breast Neoplasms (Breast Cancer)
01/2016 - 10/2009
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 01/2014
2Inflammation (Inflammations)
08/2013 - 01/2013
1Liver Neoplasms (Liver Cancer)
03/2018
1Hematologic Neoplasms (Hematological Malignancy)
03/2017
1Carcinogenesis
01/2016
1Leukemia
01/2016
1Mitochondrial Diseases (Mitochondrial Disease)
06/2014
1Herpes Zoster
01/2013
1Nasopharyngeal Carcinoma
11/2009
1Melanoma (Melanoma, Malignant)
11/2008
1Experimental Melanoma
11/2008

Drug/Important Bio-Agent (IBA)

3Histone Deacetylase InhibitorsIBA
03/2018 - 03/2013
2CateninsIBA
10/2016 - 01/2014
2Cisplatin (Platino)FDA LinkGeneric
01/2016 - 01/2014
2CurcuminIBA
06/2014 - 12/2012
2Therapeutic UsesIBA
01/2014 - 05/2011
2CytokinesIBA
08/2013 - 01/2013
2Proteins (Proteins, Gene)FDA Link
05/2011 - 11/2008
2DNA (Deoxyribonucleic Acid)IBA
10/2003 - 05/2003
2nimesulide (Aulin)IBA
10/2003 - 05/2003
1Histone Deacetylases (Histone Deacetylase)IBA
03/2018
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
03/2018
1PerforinIBA
03/2017
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2017
1Activin Receptors (Activin Receptor)IBA
10/2016
1asclepiasterolIBA
05/2016
1GlycosidesIBA
05/2016
1compound 21IBA
05/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2016
1ruxolitinibIBA
01/2016
1calotropinIBA
01/2016
1Phosphotransferases (Kinase)IBA
01/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2015
1Epidermal Growth Factor (EGF)IBA
05/2015
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2014
114-3-3 Proteins (14-3-3 Protein)IBA
06/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
06/2014
1Cadherins (E-Cadherin)IBA
01/2013
1Fibronectins (Fibronectin)IBA
01/2013
1Oxygen (Dioxygen)IBA
12/2012
1Antineoplastic Agents (Antineoplastics)IBA
12/2012
1Cancer VaccinesIBA
05/2011
1Peptides (Polypeptides)IBA
05/2011
1AntigensIBA
05/2011
1VaccinesIBA
05/2011
1Neoplasm Antigens (Tumor Antigens)IBA
05/2011
1InterferonsIBA
11/2010
1EnzymesIBA
11/2010
1Butyric Acid (Butanoic Acid)IBA
11/2010
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2009
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2009
1LigandsIBA
10/2009
1Recombinant ProteinsIBA
10/2009
1Chemokine ReceptorsIBA
10/2009
1Glutathione (Reduced Glutathione)IBA
11/2008
1Elapid Venoms (Cobra Venom)IBA
11/2003
1Dinoprostone (PGE2)FDA Link
10/2003
1Prostaglandins EIBA
05/2003
1Fluorouracil (Carac)FDA LinkGeneric
05/2003

Therapy/Procedure

6Therapeutics
03/2018 - 01/2013
2Immunotherapy
05/2011 - 11/2010
1Drug Therapy (Chemotherapy)
03/2018